| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 279.56B | 281.35B | 275.57B | 262.50B | 280.85B |
| Gross Profit | 52.19B | 144.77B | 165.68B | 131.09B | 150.43B |
| EBITDA | 27.66B | 82.20B | 49.33B | 47.38B | 98.17B |
| Net Income | 11.82B | 17.09B | 23.50B | 36.68B | 33.48B |
Balance Sheet | |||||
| Total Assets | 1.16T | 1.11T | 1.16T | 1.15T | 1.21T |
| Cash, Cash Equivalents and Short-Term Investments | 143.73B | 121.30B | 127.32B | 138.09B | 153.13B |
| Total Debt | 104.57B | 324.73B | 343.53B | 353.42B | 412.16B |
| Total Liabilities | 467.24B | 459.95B | 488.35B | 501.13B | 569.27B |
| Stockholders Equity | 562.72B | 534.72B | 548.60B | 528.07B | 525.57B |
Cash Flow | |||||
| Free Cash Flow | 43.75B | 31.88B | 26.14B | 30.86B | 12.54B |
| Operating Cash Flow | 62.46B | 54.23B | 51.44B | 56.71B | 52.18B |
| Investing Cash Flow | -6.10B | -19.90B | -15.41B | -4.36B | -550.00M |
| Financing Cash Flow | -33.96B | -40.35B | -46.78B | -67.41B | -54.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $8.04B | 23.29 | 20.28% | 0.63% | 1.23% | -22.77% | |
71 Outperform | $29.71B | 17.12 | 2.12% | 3.79% | 2.31% | -65.48% | |
69 Neutral | $145.07B | 24.26 | 31.25% | 2.24% | 7.48% | 9.55% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | $4.41B | 20.95 | 6.94% | 2.76% | -57.80% | -57.40% | |
55 Neutral | $76.03B | 37.06 | 71.89% | 1.82% | -13.09% | -20.63% | |
49 Neutral | $4.93B | -14.82 | -10.91% | 27.59% | -8.45% | 27.66% |